Clinical metabolomics: The next stage of clinical biochemistry

Blood Transfusion

Volumn 10, Issue SUPPL. 2, 2012, Pages

  D'Alessandro, Angelo ^a   Giardina, Bruno ^b   Federica, Gevi ^a   Timperio, Anna Maria ^a   Zolla, Lello ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Clinical biochemistry; Mass spectrometry; Metabolomics

Indexed keywords

NUTRACEUTICAL; OPIATE;

ABSORPTION CHROMATOGRAPHY; ANALYZER; ASSAY; AUTOMATION; BLOOD SAMPLING; COLORIMETRY; ELECTROPHORESIS; FLAME PHOTOMETRY; GENOMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPIDOMICS; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MONITORING; NANOTECHNOLOGY; NEURALGIA; NUCLEAR MAGNETIC RESONANCE; PHLEBOTOMY; PROTEOMICS; REGENERATIVE MEDICINE; REVIEW; TITRIMETRY;

EID: 84861768505     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.005S     Document Type: Review

References (70)

1. Bolodeoku J, Donaldson D. Origins of urinalysis in clinical diagnosis. J Clin Pathol 1996; 49: 623-6.
2. Olukoga AO, Bolodeoku J, Donaldson D. Origins of cerebrospinal fluid analysis in clinical diagnosis. J Clin Pathol 1997; 50: 187-92 (Pubitemid 27122794)
3. Bright R. Cases and observation illustrative of renal disease accompanied with secretion of albuminous urine. Guys Hosp Rep 1836; 1: 338.
4. Olukoga AO, Bolodeoku J, Donaldson D. Laboratory instrumentation in clinical biochemistry: an historical perspective. J R Soc Med 1997; 90(10): 570-7. (Pubitemid 27487457)
5. Petersen WS, Schmidt RE. Hospital laboratories. Surg Gynecol Obstet 1920; 31: 539-48
6. Keele KD. The impact of science on clinical methods: the basic sciences enter clinical medicine. In: The Evolution of Clinical Methods in Medicine, Part III. London: Pitman Medical; 1961. p. 50-74
7. Winsten S. The skeptical chemist. Clin Chem 1969; 15: 737-44.
8. Bowen RA, Hortin GL, Csako G, et al. Impact of blood collection devices on clinical chemistry assays. Clin Biochem. 2010; 43(1-2): 4-25.
9. Lines JG. A chronicle of the development of clinical chemistry. IFFC Newsletter 1977; 18: 3-9.
10. Greenaway F. The early development of analytical chemistry. Endeavour 1962; 21: 91.
11. Raine DN. The development of clinical chemistry up to 1900. Proc Assoc Clin Biochem 1966; 4: 89-92.
12. Walsh A. The application of atomic absorption spectra to chemical analysis. Spectrochim Acta 1955; 7: 108.
13. Tiselius A. A new apparatus for electrophoretic analysis of colloidal mixtures. A Tiselius - Trans Faraday Soc 1937; 33: 524-31.
14. De Benedetti E. Michele Tsvet, the discoverer of chromatography. Minerva Med 1956; 47(25): 536-8.
15. Skeggs LU Jr. An automatic method for colorimetric analysis. Am J Clin Pathol 1957; 28: 311
16. Rocks BF, Riley C. Automatic analysers in clinical biochemistry. Clin Phys Physiol Meas 1986; 7(1): 1-29. (Pubitemid 16142235)
17. D'Alessandro A, Zolla L. Pharmacoproteomics: a chess game on a protein field. Drug Discov Today 2010; 15(23-24): 1015-23.
18. D'Alessandro A, Zolla L. Metabolomics and cancer drug discovery: let the cells do the talking. Drug Discov Today 2012; 17(1-2): 3-9.
19. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 2008; 455 (7216): 1054-6.
20. Roux A, Lison D, Junot C, Heilier JF. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review. Clin Biochem 2011; 44(1): 119-35.
21. D'Alessandro A, Gevi F, Zolla L. Targeted mass spectrometry-based metabolomic profiling through Multiple Reaction Monitoring of Liver and other biological matrices. In Liver Proteomics. In: Josic D, Hixson DC (editors): Methods and Protocols Series: Methods in Molecular Biology, vol. 909. New York, NY, USA: Springer Protocols, Humana Press: 2012.
22. Krisp C, Randall SA, McKay MJ, Molloy MP. Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies. Proteomics Clin Appl 2012; 6(1-2): 42-59.
23. Himmelsbach M. 10 years of MS instrumental developments - impact on LC-MS/MS in clinical chemistry. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 883-884: 3-17.
24. Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem 2012; 58(1): 139-47.
25. Serkova NJ, Standiford TJ, Stringer KA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med 2011; 184(6): 647-55.
26. Christians U, Klawitter J, Hornberger A, Klawitter J. How unbiased is non-targeted metabolomics and is targeted pathway screening the solution? Curr Pharm Biotechnol 2011; 12(7): 1053-66.
27. Kortz L, Helmschrodt C, Ceglarek U. Fast liquid chromatography combined with mass spectrometry for the analysis of metabolites and proteins in human body fluids. Anal Bioanal Chem 2011; 399(8): 2635-44.
28. Antonucci R, Atzori L, Barberini L, Fanos V. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine. Minerva Pediatr 2010; 62 (3Suppl 1): 145-8.
29. Shushan B. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectrom Rev 2010; 29(6): 930-44.
30. McNiven EM, German JB, Slupsky CM. Analytical metabolomics: nutritional opportunities for personalized health. J Nutr Biochem 2011, 22(11): 995-1002.
31. Robertson DG, Watkins PB, Reily MD. Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci 2011; 120 (Suppl 1): S146-70.
32. Pichini S, Altieri I, Zuccaro P, Pacifici R. Drug monitoring in nonconventional biological fluids and matrices. Clin Pharmacokinet 1996; 30(3): 211-28. (Pubitemid 26093250)
33. Nicholson JK, Wilson ID, Lindon JC. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 2011; 12(1): 103-11.
34. Wei R. Metabolomics and its practical value in pharmaceutical industry. Curr Drug Metab 2011; 12(4): 345-58.
35. Lindon JC, Holmes E, Nicholson JK. Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 2004; 6(3): 265-72. (Pubitemid 38997127)
36. D'Alessandro A, Federica G, Palini S, et al. A mass spectrometry-based targeted metabolomics strategy of human blastocoele fluid: a promising tool in fertility research. Mol Biosyst 2012; 8(4): 953-8.
37. Nel-Themaat L, Nagy ZP. A review of the promises and pitfalls of oocyte and embryo metabolomics. Placenta 2011; 32 (Suppl 3): S257-63.
38. Singh R, Sinclair KD. Metabolomics: approaches to assessing oocyte and embryo quality. Theriogenology 2007; 68 (Suppl 1): S56-62. (Pubitemid 47096840)
39. Bromer JG, Seli E. Assessment of embryo viability in assisted reproductive technology: shortcomings of current approaches and the emerging role of metabolomics. Curr Opin Obstet Gynecol 2008; 20(3): 234-41. (Pubitemid 351643510)
40. Bowen BP, Northen TR. Dealing with the unknown: metabolomics and metabolite atlases. J Am Soc Mass Spectrom 2010; 21(9): 1471-6.
41. Vinayavekhin N, Homan EA, Saghatelian A. Exploring disease through metabolomics. ACS Chem Biol 2010; 5(1): 91-103.
42. Lane AN, Fan TW, Higashi RM, et al. Prospects for clinical cancer metabolomics using stable isotope tracers. Exp Mol Pathol 2009; 86(3): 165-73.
43. Koulman A, Lane GA, Harrison SJ, Volmer DA. From differentiating metabolites to biomarkers. Anal Bioanal Chem 2009; 394(3): 663-70.
44. Mayr M. Metabolomics: ready for the prime time? Circ Cardiovasc Genet 2008; 1(1): 58-65.
45. Gowda GA, Zhang S, Gu H, et al. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 2008; 8(5): 617-33.
46. Giovane A, Balestrieri A, Napoli C. New insights into cardiovascular and lipid metabolomics. J Cell Biochem 2008; 105(3): 648-54.
47. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 2008; 48: 653-83. (Pubitemid 351738167)
48. Holmes E, Li JV, Athanasiou T, et al. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 2011; 19(7): 349-59.
49. Holmes E, Nicholson JK. Human metabolic phenotyping and metabolome wide association studies. Ernst Schering Found Symp Proc 2007; (4): 227-49.
50. Lindon JC, Holmes E, Nicholson JK. So what's the deal with metabonomics? Anal Chem 2003; 75(17): 384A-391A. (Pubitemid 37082218)
51. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 1971; 68: 2374-6.
52. Sana TR, Waddell K, Fischer SM. A sample extraction and chromatographic strategy for increasing LC/MS detection coverage of the erythrocyte metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 871: 314-1.
53. Buescher JM, Moco S, Sauer U, Zamboni N. Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Fast and Robust Quantification of Anionic and Aromatic Metabolites. Anal Chem 2010; 82: 4403-12.
54. D'Alessandro A, Gevi F, Zolla L. A robust high resolution reversed-phase HPLC strategy to investigate various metabolic species in different biological models. Mol Biosyst 2011; 7(4): 1024-32.
55. Wishart DS. Computational approaches to metabolomics. Methods Mol Biol 2010; 593: 283-313.
56. Ekins S, Nikolsky Y, Bugrim A, et al. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007; 356: 319-50.
57. Jamshidi N, Palsson BØ. Top-down analysis of temporal hierarchy in biochemical reaction networks. PLoS Comput Biol 2008; 4(9): e1000177.
58. Jamshidi N, Palsson BØ. Systems biology of the human red blood cell. Blood Cells Mol Dis 2006; 36(2): 239-47.
59. Price ND, Reed JL, Papin JA, et al. Network-based analysis of metabolic regulation in the human red blood cell. J Theor Biol 2003; 225(2): 185-94. (Pubitemid 37324082)
60. Jamshidi N, Edwards JS, Fahland T, et al. Dynamic simulation of the human red blood cell metabolic network. Bioinformatics 2001; 17(3): 286-7. (Pubitemid 32288220)
61. D'Alessandro A, D'Amici GM, Vaglio S, Zolla L. Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica 2012; 97(1): 107-15.
62. Pallotta V, D'Amici GM, D'Alessandro A, et al. Red blood cell processing for cryopreservation: from fresh blood to deglycerolization. Blood Cells Mol Dis 2012; DOI: 10.1016/j.bcmd.2012.02.004
63. Gevi F, D'Alessandro A, Rinalducci S, Zolla L. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012; DOI: 10.1016/j.jprot.2012.03.012.
64. Nicolardi S, Palmblad M, Hensbergen PJ, et al. Precision profiling and identification of human serum peptides using Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 2011; 25(23): 3457-63.
65. Cullum BM, Vo-Dinh T. The development of optical nanosensors for biological measurements. Trends Biotechnol 2000; 18(9): 388-93.
66. Jeffery CJ. Engineering periplasmic ligand binding proteins as glucose nanosensors. Nano Rev 2011; 2. DOI: 10.3402/nano.v2i0.5743.
67. D'Alessandro A, Zolla L. We are what we eat: food safety and proteomics. J Proteome Res 2012; 11(1): 26-36.
68. D'Alessandro A, Rinalducci S, Zolla L. Redox proteomics and drug development. J Proteomics 2011; 74(12): 2575-95.
69. D'Alessandro A, Liumbruno G, Grazzini G, et al. Umbilical cord blood stem cells: towards a proteomic approach. J Proteomics 2010; 73(3): 468-82.
70. Whitsett C, Vaglio S, Grazzini G. Alternative Blood Products and Clinical Needs in Transfusion Medicine. Stem Cells International 2012; DOI: 10.1155/2012/639561.